Schedule I (Tables)

12 Months Ended

Dec. 31, 2021

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets


(in millions, except per share data)	December 31, 2021		December 31, 2020
Assets
Current assets:
Cash and cash equivalents	$	2,167	$	258
Other current assets	503		562
Total current assets	2,670		820
Equity in net assets of subsidiaries	116,907		107,714
Long-term notes receivable from subsidiaries	5,680		5,021
Other assets	32		342
Total assets	$	125,289	$	113,897

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	605	$	589
Current portion of notes payable to subsidiaries	8,105		4,882
Short-term borrowings and current maturities of long-term debt	3,009		4,465
Total current liabilities	11,719		9,936
Long-term debt, less current maturities	41,623		37,815
Other liabilities	187		655
Total liabilities	53,529		48,406
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—		—
Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding	10		10
Additional paid-in capital	—		—
Retained earnings	77,134		69,295
Accumulated other comprehensive loss	(5,384)		(3,814)
Total UnitedHealth Group shareholders’ equity	71,760		65,491
Total liabilities and shareholders’ equity	$	125,289	$	113,897

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income


	For the Years Ended December 31,
(in millions)	2021		2020		2019
Revenues:
Investment and other income	$	494	$	194	$	209
Total revenues	494		194		209
Operating costs:
Operating costs	40		27		38
Interest expense	1,583		1,594		1,580
Total operating costs	1,623		1,621		1,618
Loss before income taxes	(1,129)		(1,427)		(1,409)
Benefit for income taxes	231		300		293
Loss of parent company	(898)		(1,127)		(1,116)
Equity in undistributed income of subsidiaries	18,183		16,530		14,955
Net earnings	17,285		15,403		13,839
Other comprehensive (loss) income	(1,570)		(236)		582
Comprehensive income	$	15,715	$	15,167	$	14,421

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows


	For the Years Ended December 31,
(in millions)	2021		2020		2019
Operating activities
Cash flows from operating activities	$	11,439	$	8,842	$	9,275
Investing activities
Issuances of notes to subsidiaries	(444)		(628)		(2,722)
Repayments of notes to subsidiaries	37		1,089		2,249
Cash paid for acquisitions	(4,953)		(7,706)		(9,645)
Return of capital to parent company	245		943		4,497
Capital contributions to subsidiaries	(747)		(43)		(803)
Other, net	—		143		490
Cash flows used for investing activities	(5,862)		(6,202)		(5,934)
Financing activities
Common stock repurchases	(5,000)		(4,250)		(5,500)
Proceeds from common stock issuances	1,355		1,440		1,037
Cash dividends paid	(5,280)		(4,584)		(3,932)
(Repayments of) proceeds from short-term borrowings, net	(1,302)		872		300
Proceeds from issuance of long-term debt	6,933		4,864		5,444
Repayments of long-term debt	(3,150)		(3,150)		(1,750)
Proceeds from notes from subsidiaries	3,223		2,818		1,207
Other, net	(447)		(438)		(535)
Cash flows used for financing activities	(3,668)		(2,428)		(3,729)
Increase (decrease) in cash and cash equivalents	1,909		212		(388)
Cash and cash equivalents, beginning of period	258		46		434
Cash and cash equivalents, end of period	$	2,167	$	258	$	46

Supplemental cash flow disclosures
Cash paid for interest	$	1,575	$	1,633	$	1,506
Cash paid for income taxes	3,050		4,185		2,590

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows: